ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

New CREGs Announced In Epidemiology, Viruses, Carcinogenesis

April 23, 1976

RFPs Available

May 5, 2000

How to Become a Urology Millionaire…Alas, One Little Problem—Overtreatment

April 13, 2012

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

Medenica’s Claims Of Association On CV, Brochures, Challenged By Some Institutions

April 30, 1993

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014